Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
04/2013
04/02/2013US8410110 9-(piperazinylalkyl) carbazoles as Bax-modulators
03/2013
03/28/2013WO2013042124A1 Use of strigolactones and strigolactone analogs for treating proliferative conditions
03/28/2013WO2013041652A1 Morpholino substituted urea or carbamate derivatives as mtor inhibitors
03/28/2013WO2012052491A3 1-(heterocyclic carbonyl)-2-substituted pyrrolidines and their use as fungicides
03/28/2013US20130079490 NORBORNANE-2-SPIRO-alpha-CYCLOALKANONE-alpha'-SPIRO-2''-NORBORNANE-5,5'',6,6''-TETRACARBOXYLIC DIANHYDRIDE, NORBORNANE-2-SPIRO-alpha-CYCLOALKANONE-alpha'-SPIRO-2''-NORBORNANE-5,5'',6,6''-TETRACARBOXYLIC ACID AND ESTER THEREOF, METHOD FOR PRODUCING NORBORNANE-2-SPIRO-alpha-CYCLOALKANONE-alpha'-SPIRO-2''-NORBORNANE-5,5'',6,6''-TETRACARBOXYLIC DIANHYDRIDE, POLYIMIDE OBTAINED BY USING THE SAME, AND METHOD FOR PRODUCING POLYIMIDE
03/28/2013CA2849343A1 Use of strigolactones and strigolactone analogs for treating proliferative conditions
03/28/2013CA2849189A1 Morpholino substituted urea or carbamate derivatives as mtor inhibitors
03/27/2013CN103003263A Novel hetaryl (thio)carboxamide compounds for controlling invertebrate pests
03/27/2013CN102993188A Fradimycin B as well as preparation method and application thereof
03/27/2013CN102993187A Method for extracting silymarin by nitrogen protection
03/27/2013CN102993148A Quercetin derivatives or analogs thereof, and application thereof
03/27/2013CN102989004A Brain-targeting prodrug with vitamin C as carrier
03/27/2013CN102010281B Preparation method of alpha-acyloxy ether
03/27/2013CN101679287B Nicotinic acetylcholine receptor modulators
03/27/2013CN101558040B Dihydropyridine derivatives useful as protein kinase inhibitors
03/27/2013CN101321727B 肟酯光敏引发剂 Oxime ester photoinitiator
03/27/2013CN101296907B Diaminopyrimidines as P2X3 and P2X2/3 modulators
03/27/2013CN101185611B Technique for preparing silybin fine particles by using supercritical fluid crystallization technology
03/21/2013WO2013037896A1 Disubstituted 5-fluoro-pyrimidines
03/21/2013WO2013037753A1 Plant growth regulating compounds
03/21/2013US20130072461 Triazole compounds that modulate hsp90 activity
03/21/2013CA2848616A1 Disubstituted 5-fluoro-pyrimidines
03/21/2013CA2848226A1 Plant growth regulating compounds
03/20/2013EP2569306A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
03/20/2013EP2569303A1 Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
03/20/2013EP2569292A1 Polysubstituted benzofurans and medicinal applications thereof
03/14/2013WO2013036671A1 Compounds useful for treating neurodegenerative disorders
03/14/2013WO2013033901A1 Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
03/14/2013WO2013033900A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
03/13/2013EP2566853A1 Tetrazolones as inhibitors of fatty acid synthase
03/13/2013CN102964342A Method for quickly precipitating and solidifying washing silymarin in process of removing solvent residue
03/13/2013CN102964239A Metallo-beta-lactamase inhibitor
03/13/2013CN102153534B Compound with tyrosinase inhibitory activity as well as preparation method and application thereof
03/07/2013WO2013032960A2 Vitamin d receptor - coregulator inhibitors
03/07/2013WO2013032297A1 Benzocarbazole compounds and electroluminescent devices involving them
03/07/2013WO2013032278A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/07/2013WO2013029479A1 Mycophenolic acid derivative and preparation method and use thereof
03/07/2013US20130059853 Biaryl phosphodiesterase inhibitors
03/06/2013CN102952105A Mycophenolic acid derivative, preparation method thereof and application thereof
03/06/2013CN101723939B Isopentenyl-oxyl substituted dehydrogenized silybin ether and preparation method and application thereof
03/05/2013US8389571 Benzofuran derived HIV protease inhibitors
03/05/2013US8389073 Four-ring liquid crystal compound having tetrahydropyran and 2,2′,3,3′-tetrafluorobiphenyl, liquid crystal composition and liquid crystal display device
02/2013
02/28/2013WO2013028045A2 Epoxy compound having alkoxysilyl group, method for preparing same, composition and cured material comprising same, and usage thereof
02/28/2013WO2013027001A1 Compounds and their use to treat histamine h3 related disorders
02/28/2013WO2013027000A1 Pyridazinone compounds and their use as daao inhibitors
02/28/2013WO2013026726A1 Dihydrofuran derivatives as insecticidal compounds
02/28/2013WO2013026724A1 Dihydrofuran derivatives as insecticidal compounds
02/28/2013WO2012173842A3 Purification process for para-methallylpyrocatechol
02/28/2013WO2012149157A3 Heterocyclic compounds for the inhibition of pask
02/28/2013US20130053564 Ketal amide compounds, methods of making, and applications
02/28/2013US20130053436 Compounds, compositions and methods
02/28/2013US20130048955 Heterocyclic compound and organic light-emitting device containing the same
02/28/2013CA2846204A1 Pyridazinone compounds and their use as daao inhibitors
02/27/2013EP2562174A1 Herbicidal 6-Oxo-1,6-dihydropyrimidin-5-carboxamides and 2-Oxo-1,2-dihydropyridin-3-carboxamides
02/27/2013EP2562171A1 Germination-stimulant carbamate derivatives and process for preparation thereof
02/27/2013CN102947294A Novel organic electroluminescent compounds and organic electroluminescent device using the same
02/26/2013US8383675 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
02/26/2013US8383651 Compounds which selectively modulate the CB2 receptor
02/21/2013WO2013025074A2 Anticancer or antioxidant composition containing quamoclit pennata extract or compound derived from quamoclit pennata extract
02/21/2013WO2013024968A1 Novel compound isolated from quamoclit, and composition for preventing or treating diabetes containing the compound as an active ingredient
02/21/2013US20130046102 Glyceryl ether compounds and their use
02/21/2013CA2845496A1 Novel compound isolated from quamoclit, and composition for preventing or treating diabetes containing the compound as an active ingredient
02/20/2013CN102939286A Polysubstituted benzofurans and medicinal applications thereof
02/20/2013CN102936242A Method for comprehensively utilizing arrowroot
02/19/2013US8377963 Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof
02/14/2013WO2013020930A1 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
02/14/2013WO2013020370A1 Pim kinase inhibitor and preparation method and use in medicinal manufacture thereof
02/14/2013US20130041165 Process for preparing divinylarene dioxides
02/14/2013US20130040389 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
02/14/2013CA2844852A1 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof
02/14/2013CA2844275A1 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
02/13/2013CN202724906U Silymarine extracting tank foam catcher with strainer
02/13/2013CN202724804U Leakage-proof filter of silymarine extracting tank
02/13/2013CN202724742U Combined type recovery condenser of silymarine extracting tank
02/13/2013CN202724741U Cooling device for silymarin extracting tank
02/13/2013CN102933561A Pharmaceutically active disubstituted triazine derivatives
02/13/2013CN102933214A 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1)
02/13/2013CN102924438A Method for extracting silymarin and silybum mariamum oil from silybum mariamum seed
02/13/2013CN102924421A Preparation method and application of compound having tyrosinase inhibitory activity
02/13/2013CN102920727A Method for preparing extracts rich in vitexin rhamnoside and vitexin glucoside
02/13/2013CN101712676B Water soluble puerarin derivatives and preparation method and application thereof
02/12/2013CA2571587C Quaternary salt ccr2 antagonists
02/12/2013CA2557260C Triptolide lactone ring derivatives as immunomodulators and anticancer agents
02/07/2013WO2013019662A1 Aryl naphthalide lignans as anti-hiv agents
02/07/2013WO2013018053A1 Process for the preparation of epoxides as intermediates for the synthesis of nebivolol
02/07/2013US20130035323 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
02/07/2013US20130035304 Small molecules for the modulation of mcl-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders
02/07/2013US20130035270 Friction Reducing Additive
02/06/2013EP2552888A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion"
02/06/2013CN102911112A Heterocyclic compound and organic light-emitting device including the same
02/06/2013CN102093342B C-28 toosendanin carboxylic ester derivatives and application of C-28 toosendanin carboxylic ester derivative in preparing plant source pesticide
02/06/2013CN101553485B Process for preparing nebivolol
02/05/2013US8367224 Organic electroluminescence element, new compound for the same, display device and lighting device using the same
02/05/2013CA2591033C Heterocyclic aspartyl protease inhibitors
02/05/2013CA2411315C Method for detecting a detectable product
01/2013
01/31/2013WO2013016120A1 Pederin and psymberin agents
01/31/2013US20130030009 Method for the treatment and/or prevention of oral allergic symptions of the lips due to oral contact with a food allergen
01/31/2013US20130029941 7,11-methanocycloocta [b] quinoline derivative as highly functionalizable acetylcholinesterase inhibitors
01/31/2013US20130029936 Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same
01/31/2013US20130028837 Contrast agents for myocardial perfusion imaging
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 120